Advanced Life Sciences Holdings, Inc. · Woodridge, IL United States (OTC: ADLS)
| 1440 Davey Rd. | Phone: 630-739-6744 |
| Woodridge, IL | Fax: 630-739-6754 |
| 60517 | |
| United States | 
Map This Company |
Advanced Life Sciences Holdings, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Seeking to advance life through science, Advanced Life Sciences is a biopharmaceutical company that develops clinical and preclinical drug candidates for infectious disease, cancer, and respiratory diseases. Its lead candidate Restanza (cethromycin), an antibiotic for treatment of respiratory infections and pneumonia, has been submitted to the FDA for approval. Restanza is also being studied for use in the biodefense sector to treat pathogens such as anthrax. The biopharmaceutical company's other drug candidates include treatments for metastatic melanoma and acute respiratory distress. Advanced Life Sciences has licensed the development and commercialization rights to cethromycin from
Advanced Life Sciences Holdings, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: ADLS Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 16 |
Executives
18 executives listed for Advanced Life Sciences Holdings, Inc.'s Woodridge, IL location.
| Chairman and CEO | Michael Flavin | |
|---|---|---|
| President, CFO, Secretary, and Director | John Flavin | |
| EVP and Chief Scientific Officer | Ze-Qi Xu |